Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): Comparison between 2 different schedules.
Τίτλος | Orthovoltage radiotherapy for nonmelanoma skin cancer (NMSC): Comparison between 2 different schedules. |
Publication Type | Journal Article |
Year of Publication | 2016 |
Authors | Pampena, R., Palmieri T., Kyrgidis A., Ramundo D., Iotti C., Lallas A., Moscarella E., Borsari S., Argenziano G., & Longo C. |
Journal | J Am Acad Dermatol |
Volume | 74 |
Issue | 2 |
Pagination | 341-7 |
Date Published | 2016 Feb |
ISSN | 1097-6787 |
Λέξεις κλειδιά | Aged, Aged, 80 and over, Appointments and Schedules, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Disease-Free Survival, Dose Fractionation, Radiation, Female, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Neoplasm Recurrence, Local, Proportional Hazards Models, Retrospective Studies, Skin Neoplasms, Survival Rate, Treatment Outcome |
Abstract | BACKGROUND: Radiotherapy is an established treatment for some types of patients with nonmelanoma skin cancer. A hypofractionated schedule has been proposed as a valuable option for elderly disabled patients to minimize the number of hospital visits.OBJECTIVE: We sought to compare a weekly hypofractionated orthovoltage radiotherapy regimen with a standard daily one for the treatment of nonmelanoma skin cancer.METHODS: A retrospective cohort study was performed on 436 tumors. Overall survival, disease-free survival, and cosmetic outcome were measured. Life-table analysis, Kaplan-Meier survival analysis, and multivariate Cox regression model were performed.RESULTS: The hypofractionated regimen was not associated with increased recurrence rates and mortality, or with a poorer cosmetic outcome, when compared with the daily schedule.LIMITATIONS: Absence of complete information about acute treatment toxicity and a shorter follow-up time for patients receiving the weekly schedule are limitations of this study.CONCLUSIONS: A weekly hypofractionated regimen of orthovoltage radiotherapy seems to be the most appropriate approach in elderly disabled patients with nonmelanoma skin cancers. |
DOI | 10.1016/j.jaad.2015.09.031 |
Alternate Journal | J Am Acad Dermatol |
PubMed ID | 26589877 |